Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2022-02-14
3:00 pm
Purchase
13GEledon Pharmaceuticals, Inc.
ELDN
Cormorant Asset Management, LP1,428,598
9.9%
1,428,598increase
(New Position)
View
2022-02-11
07:20 am
Purchase
13GEledon Pharmaceuticals, Inc.
ELDN
Woodline Partners LP685,273
4.8%
685,273increase
(New Position)
View
2022-02-10
09:01 am
Unchanged
13GEledon Pharmaceuticals, Inc.
ELDN
ADAGE CAPITAL PARTNERS GP, L.L.C.0
0%
0
(Unchanged)
View
2022-02-09
09:11 am
Purchase
13GEledon Pharmaceuticals, Inc.
ELDN
FMR LLC504,371
3.525%
504,371increase
(New Position)
View
2022-01-28
4:35 pm
Purchase
13GEledon Pharmaceuticals, Inc.
ELDN
BIOTECHNOLOGY VALUE FUND L P2,326,710
16.9%
878,690increase
(+60.68%)
View
2022-01-26
4:27 pm
Sale
13GEledon Pharmaceuticals, Inc.
ELDN
Logos Global Management LP0
0%
-1,339,793decrease
(Position Closed)
View
2022-01-10
5:57 pm
Purchase
13GEledon Pharmaceuticals, Inc.
ELDN
BIOTECHNOLOGY VALUE FUND L P1,448,020
10.1%
13,088increase
(+0.91%)
View
2022-01-10
5:51 pm
Purchase
13GEledon Pharmaceuticals, Inc.
ELDN
BIOTECHNOLOGY VALUE FUND L P1,434,932
9.99%
1,434,932increase
(New Position)
View
2021-09-09
12:30 pm
Purchase
13GEledon Pharmaceuticals, Inc.
ELDN
Logos Global Management LP1,339,793
9.4%
1,339,793increase
(New Position)
View
2021-02-16
4:35 pm
Purchase
13GEledon Pharmaceuticals, Inc.
ELDN
Woodline Partners LP814,756
5.4%
814,756increase
(New Position)
View
2021-02-16
4:17 pm
Sale
13GEledon Pharmaceuticals, Inc.
ELDN
BIOTECHNOLOGY VALUE FUND L P1,503,121
9.99%
-14,918decrease
(-0.98%)
View
2021-02-16
3:14 pm
Purchase
13GEledon Pharmaceuticals, Inc.
ELDN
683 Capital Management, LLC35,900
1%
35,900increase
(New Position)
View
2021-02-08
10:29 am
Purchase
13GEledon Pharmaceuticals, Inc.
ELDN
FMR LLC1,004,111
6.623%
1,004,111increase
(New Position)
View
2021-01-05
4:38 pm
Unchanged
13DEledon Pharmaceuticals, Inc.
ELDN
OrbiMed Israel BioFund GP Limited Partnership73,650
0.5%
0
(Unchanged)
View
2021-01-04
4:06 pm
Purchase
13GEledon Pharmaceuticals, Inc.
ELDN
ADAGE CAPITAL PARTNERS GP, L.L.C.892,555
5.89%
892,555increase
(New Position)
View
2021-01-04
4:01 pm
Purchase
13GEledon Pharmaceuticals, Inc.
ELDN
Cormorant Asset Management, LP1,415,500
9.89%
1,415,500increase
(New Position)
View
2020-12-30
5:27 pm
Purchase
13GEledon Pharmaceuticals, Inc.
ELDN
BIOTECHNOLOGY VALUE FUND L P1,518,039
10%
3,520increase
(+0.23%)
View
2020-12-28
5:13 pm
Purchase
13GEledon Pharmaceuticals, Inc.
ELDN
BIOTECHNOLOGY VALUE FUND L P1,514,519
9.99%
1,319,193increase
(+675.38%)
View
2020-12-04
5:12 pm
Sale
13DEledon Pharmaceuticals, Inc.
ELDN
OrbiMed Israel BioFund GP Limited Partnership73,650
5.1%
-103,200decrease
(-58.35%)
View
2020-11-20
4:39 pm
Unchanged
13DEledon Pharmaceuticals, Inc.
ELDN
OrbiMed Israel BioFund GP Limited Partnership176,850
12.4%
0
(Unchanged)
View
Goto 0, 1, Next